← Leaderboards
Asher D Schachter
Children'S Hospital Boston
$1,305,751
Attributed
$1,404,199
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $460.3K · FY2006–09$500K$375K$250K$125K$0
'06
'07
'08
'09
Funding mix
By agency
NIH$1,404,199 · 4
By mechanism
R01$628,692 · 1
K23$627,097 · 1
R43$147,672 · 1
M01$738 · 1
Top collaborators
- Jeff Scott Behrens1 shared
- Mohsen D. Ghassemi1 shared
Most similar at Children'S Hospital Boston
Same institution · by research overlap
- Alicia Rivera$2,766,671
- Ben Y Reis$7,460,274
Others in their field
Top investigators on “Polymerase Chain Reaction”
- Richard A Gibbs · Baylor College Of Medicine$161,803,490
- Norman Wolmark · Nsabp Foundation, Inc.$79,506,229
- David Heimbrook · Leidos Biomedical Research, Inc.$70,580,438
- Constance Ann Benson · University Of California, San Diego$66,635,731
- Eric S Lander · Whitehead Institute For Biomedical Res$52,964,838
- Thomas William Geisbert · Boston University Medical Campus$36,787,680
Research focus
Polymerase Chain ReactionSteroidsPathologic ProcessPhenotypePrednisoneRelapse /RecurrenceHormone TherapyNuclear Factor Kappa BetaHormone Sensitivity /ResistancePediatric PharmacologyHuman SubjectPostoperative ComplicationsImmune Tolerance /UnresponsivenessI Kappa B BetaChild (0-11)Chronic Renal FailureKidney TransplantationNephrotic SyndromeBiological Signal TransductionClinical ResearchGlucocorticoidsGene ExpressionCareerTransplantation Immunology
Grant awards (9)
Preclinical predictive markers of post-approval drug safety$316,042
R01 · FY2009 · GM · contact PI
Preclinical predictive markers of post-approval drug safety$312,650
R01 · FY2008 · GM · contact PI
Decision support software for cancer drug development$147,672
R43 · FY2008 · CA
METRONOMIC DOSING OF CYCLOPHOSPHAMIDE AND THROMBOSPONDIN LEVELS IN IDIOPATHIC NE$738
M01 · FY2006 · RR · contact PI
Mentored Patient-Oriented Research Career Development Aw$125,496
K23 · FY2004 · RR
Mentored Patient-Oriented Research Career Development Aw$125,496
K23 · FY2003 · RR
Mentored Patient-Oriented Research Career Development Aw$125,496
K23 · FY2002 · RR
Mentored Patient-Oriented Research Career Development Aw$125,400
K23 · FY2001 · RR
Mentored Patient-Oriented Research Career Development Aw$125,209
K23 · FY2000 · RR